You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 295 No. 14, April 12, 2006 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Editorial
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (49)
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in JAMA
 Topic Collections
 •Endocrine Diseases
 •Diabetes Mellitus
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Glycemic Variability: A Hemoglobin A1c–Independent Risk Factor for Diabetic Complications

Michael Brownlee, MD; Irl B. Hirsch, MD

JAMA. 2006;295:1707-1708.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Diabetes affects an estimated 20.8 million individuals in the United States, 7% of the current population, and the lifetime risk of developing diabetes for those born in the year 2000 is 35%.1-2 Many of these individuals will develop diabetes-specific microvascular pathology in the retina, renal glomerulus, and peripheral nerve and accelerated atherosclerotic macrovascular disease affecting arteries that supply the heart, brain, and lower extremities. In both type 1 and type 2 diabetes, large prospective clinical studies have shown a strong relationship between time-averaged mean levels of glycemia, measured as hemoglobin A1c (HbA1c), and diabetic complications.3-4 These studies are the basis for the American Diabetes Association's current recommended treatment goal that HbA1c should be less than 7%.5 However, only about a third of patients diagnosed as having diabetes achieve that goal.6 Even fewer reach the target level for HbA1c of 6.5% advocated by . . . [Full Text of this Article]

Author Affiliations: JDRF International Center for Diabetic Complications Research, Albert Einstein College of Medicine, Bronx, NY (Dr Brownlee); and University of Washington School of Medicine, Diabetes Care Center, Seattle (Dr Hirsch).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLES

Activation of Oxidative Stress by Acute Glucose Fluctuations Compared With Sustained Chronic Hyperglycemia in Patients With Type 2 Diabetes
Louis Monnier, Emilie Mas, Christine Ginet, Françoise Michel, Laetitia Villon, Jean-Paul Cristol, and Claude Colette
JAMA. 2006;295(14):1681-1687.
ABSTRACT | FULL TEXT  

Assessing Glycemia in Diabetes Using Self-monitoring Blood Glucose and Hemoglobin A1c
Christopher D. Saudek, Rachel L. Derr, and Rita R. Kalyani
JAMA. 2006;295(14):1688-1697.
ABSTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Application of muscle biopotential measurement for sustained, noninvasive blood glucose survey
Vol et al.
J. Appl. Physiol. 2009;107:253-260.
ABSTRACT | FULL TEXT  

Reference Values for Continuous Glucose Monitoring in Chinese Subjects
Zhou et al.
Diabetes Care 2009;32:1188-1193.
ABSTRACT | FULL TEXT  

Glycemic Variability Correlates Strongly With Postprandial{beta}-Cell Dysfunction in a Segment of Type 2 Diabetic Patients Using Oral Hypoglycemic Agents
Kohnert et al.
Diabetes Care 2009;32:1058-1062.
ABSTRACT | FULL TEXT  

Comparison of Glycemic Variability Associated With Insulin Glargine and Intermediate-Acting Insulin When Used as the Basal Component of Multiple Daily Injections for Adolescents With Type 1 Diabetes
White et al.
Diabetes Care 2009;32:387-393.
ABSTRACT | FULL TEXT  

American College of Endocrinology Pre-Diabetes Consensus Conference: Part Three
Bloomgarden
Diabetes Care 2008;31:2404-2409.
FULL TEXT  

A1C Variability and the Risk of Microvascular Complications in Type 1 Diabetes: Data from the Diabetes Control and Complications Trial
Kilpatrick et al.
Diabetes Care 2008;31:2198-2202.
ABSTRACT | FULL TEXT  

Effect of Glycemic Exposure on the Risk of Microvascular Complications in the Diabetes Control and Complications Trial--Revisited
Lachin et al.
Diabetes 2008;57:995-1001.
ABSTRACT | FULL TEXT  

Renal complications of childhood type 1 diabetes
Carel and Levy-Marchal
BMJ 2008;336:677-678.
FULL TEXT  

Self-Monitoring of Blood Glucose Before and After Medicare Expansion Among Medicare Beneficiaries With Diabetes Who Do Not Use Insulin
Li et al.
AJPH 2008;98:358-364.
ABSTRACT | FULL TEXT  

Dietary Strategies for Improving Post-Prandial Glucose, Lipids, Inflammation, and Cardiovascular Health
O'Keefe et al.
J Am Coll Cardiol 2008;51:249-255.
ABSTRACT | FULL TEXT  

Influence of Mulberry Leaf Extract on the Blood Glucose and Breath Hydrogen Response to Ingestion of 75 g Sucrose by Type 2 Diabetic and Control Subjects
Mudra et al.
Diabetes Care 2007;30:1272-1274.
FULL TEXT  

Assessing Glycemic Control With Self-monitoring of Blood Glucose and Hemoglobin A1c Measurements
Dailey
Mayo Clin Proc. 2007;82:229-236.
ABSTRACT | FULL TEXT  

Glucose Fluctuations and Oxidative Stress--Reply
Monnier et al.
JAMA 2006;296:1730-1731.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2006 American Medical Association. All Rights Reserved.